Future Directions in Dendritic Cell Research in Cancer

  • Madhav V. DhodapkarEmail author


Dendritic cells play a critical role in the regulation of both innate and adaptive immunities. Tumors can exploit the biology of these cells to both evade immunity and facilitate their growth. Although much has been learnt about the biology of these cells, much more remains to be discovered. It is likely that several aspects of the host immune response to tumor cells are conditioned by the interactions of dendritic cells and tumor cells. Dendritic cells may also have non-immune effects on the biology and growth of tumor cells. Improved understanding of how tumor cells interact with dendritic cells therefore has implications for both cancer biology and immunity to tumors.


Dendritic Cell Myeloid Dendritic Cell Premetastatic Niche Myeloid Suppressor Cell Diverse Subset 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



MVD is supported in part by funds from NIH, Dana Foundation, and Damon Runyon Cancer Research Fund. I thank Kavita Dhodapkar for critically reading this review.


  1. Albert, M. L., Sauter, B. and Bhardwaj, N. 1998. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392:86–89.PubMedCrossRefGoogle Scholar
  2. Aspord, C., Pedroza-Gonzalez, A., Gallegos, M., Tindle, S., Burton, E. C., Su, D., Marches, F., Banchereau, J. and Palucka, A. K. 2007. Breast cancer instructs dendritic cells to prime interleukin 13-secreting CD4+ T cells that facilitate tumor development. J Exp Med 204:1037–1047.PubMedCrossRefGoogle Scholar
  3. Bahlis, N. J., King, A. M., Kolonias, D., Carlson, L. M., Liu, H. Y., Hussein, M. A., Terebelo, H. R., Byrne, G. E., Jr., Levine, B. L., Boise, L. H. and Lee, K. P. 2007. CD28-mediated regulation of multiple myeloma cell proliferation and survival. Blood 109:5002–5010.PubMedCrossRefGoogle Scholar
  4. Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y. J., Pulendran, B. and Palucka, K. 2000. Immunobiology of dendritic cells. Annu Rev Immunol 18:767–811.PubMedCrossRefGoogle Scholar
  5. Banchereau, J. and Palucka, A. K. 2005. Dendritic cells as therapeutic vaccines against cancer. Nat Rev Immunol 5:296–306.PubMedCrossRefGoogle Scholar
  6. Banerjee, D. K., Dhodapkar, M. V., Matayeva, E., Steinman, R. M. and Dhodapkar, K. M. 2006. Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients. Blood 108:2655–2661.PubMedCrossRefGoogle Scholar
  7. Bell, D., Chomarat, P., Broyles, D., Netto, G., Harb, G. M., Lebecque, S., Valladeau, J., Davoust, J., Palucka, K. A. and Banchereau, J. 1999. In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas. J Exp Med 190:1417–1426.PubMedCrossRefGoogle Scholar
  8. Bozzacco, L., Trumpfheller, C., Siegal, F. P., Mehandru, S., Markowitz, M., Carrington, M., Nussenzweig, M. C., Piperno, A. G. and Steinman, R. M. 2007. DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes. Proc Natl Acad Sci USA 104:1289–1294.PubMedCrossRefGoogle Scholar
  9. Charalambous, A., Oks, M., Nchinda, G., Yamazaki, S. and Steinman, R. M. 2006. Dendritic cell targeting of survivin protein in a xenogeneic form elicits strong CD4+ T cell immunity to mouse survivin. J Immunol 177:8410–8421.PubMedGoogle Scholar
  10. Coukos, G., Benencia, F., Buckanovich, R. J. and Conejo-Garcia, J. R. 2005. The role of dendritic cell precursors in tumour vasculogenesis. Br J Cancer 92:1182–1187.PubMedCrossRefGoogle Scholar
  11. Coussens, L. M. and Werb, Z. 2002. Inflammation and cancer. Nature 420:860–867.PubMedCrossRefGoogle Scholar
  12. de Vries, I. J., Lesterhuis, W. J., Barentsz, J. O., Verdijk, P., van Krieken, J. H., Boerman, O. C., Oyen, W. J., Bonenkamp, J. J., Boezeman, J. B., Adema, G. J., Bulte, J. W., Scheenen, T. W., Punt, C. J., Heerschap, A. and Figdor, C. G. 2005. Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat Biotechnol 23:1407–1413.PubMedCrossRefGoogle Scholar
  13. Dhodapkar, K. M., Kaufman, J. L., Ehlers, M., Banerjee, D. K., Bonvini, E., Koenig, S., Steinman, R. M., Ravetch, J. V. and Dhodapkar, M. V. 2005. Selective blockade of inhibitory Fcgamma receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells. Proc Natl Acad Sci USA 102:2910–2915.PubMedCrossRefGoogle Scholar
  14. Dhodapkar, M. V. 2009. Harnessing human CD1d restricted T cells for tumor immunity: progress and challenges. Front Biosci in press.Google Scholar
  15. Dhodapkar, M. V., Dhodapkar, K. M. and Palucka, A. K. 2008. Interactions of tumor cells with dendritic cells: balancing immunity and tolerance. Cell Death Differ 15:39–50.PubMedCrossRefGoogle Scholar
  16. Garrett, W. S., 1Lord, G. M., Punit, S., Lugo-Villarino, G., Mazmanian, S. K., Ito, S., Glickman, J. N. and Glimcher, L. H. 2007. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell 131:33–45.PubMedCrossRefGoogle Scholar
  17. Gilboa, E. 1999. The makings of a tumor rejection antigen. Immunity 11:263–270.PubMedCrossRefGoogle Scholar
  18. Grimshaw, M. J. and Balkwill, F. R. 2001. Inhibition of monocyte and macrophage chemotaxis by hypoxia and inflammation--a potential mechanism. Eur J Immunol 31:480–489.PubMedCrossRefGoogle Scholar
  19. Gutcher, I. and Becher, B. 2007. APC-derived cytokines and T cell polarization in autoimmune inflammation. J Clin Invest 117:1119–1127.PubMedCrossRefGoogle Scholar
  20. Hart, A. L., Al-Hassi, H. O., Rigby, R. J., Bell, S. J., Emmanuel, A. V., Knight, S. C., Kamm, M. A. and Stagg, A. J. 2005. Characteristics of intestinal dendritic cells in inflammatory bowel diseases. Gastroenterology 129:50–65.PubMedCrossRefGoogle Scholar
  21. Hawiger, D., Inaba, K., Dorsett, Y., Guo, M., Mahnke, K., Rivera, M., Ravetch, J. V., Steinman, R. M. and Nussenzweig, M. C. 2001. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med 194:769–779.PubMedCrossRefGoogle Scholar
  22. Heath, W. R. and Carbone, F. R. 2001. Cross-presentation, dendritic cells, tolerance and immunity. Annu Rev Immunol 19:47–64.PubMedCrossRefGoogle Scholar
  23. Jakubzick, C., Tacke, F., Ginhoux, F., Wagers, A. J., van Rooijen, N., Mack, M., Merad, M. and Randolph, G. J. 2008. Blood monocyte subsets differentially give rise to CD103+ and CD103- pulmonary dendritic cell populations. J Immunol 180:3019–3027.PubMedGoogle Scholar
  24. Jakubzick, C., Tacke, F., Llodra, J., van Rooijen, N. and Randolph, G. J. 2006. Modulation of dendritic cell trafficking to and from the airways. J Immunol 176:3578–3584.PubMedGoogle Scholar
  25. Kortylewski, M., Kujawski, M., Wang, T., Wei, S., Zhang, S., Pilon-Thomas, S., Niu, G., Kay, H., Mule, J., Kerr, W. G., Jove, R., Pardoll, D. and Yu, H. 2005. Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity. Nat Med 11:1314–1321.PubMedCrossRefGoogle Scholar
  26. Kukreja, A., Hutchinson, A., Dhodapkar, K., Mazumder, A., Vesole, D., Angitapalli, R., Jagannath, S. and Dhodapkar, M. V. 2006. Enhancement of clonogenicity of human multiple myeloma by dendritic cells. J Exp Med 203:1859–1865.PubMedCrossRefGoogle Scholar
  27. Mahnke, K., Guo, M., Lee, S., Sepulveda, H., Swain, S. L., Nussenzweig, M. and Steinman, R. M. 2000. The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments. J Cell Biol 151:673–684.PubMedCrossRefGoogle Scholar
  28. Mahnke, K., Qian, Y., Fondel, S., Brueck, J., Becker, C. and Enk, A. H. 2005. Targeting of antigens to activated dendritic cells in vivo cures metastatic melanoma in mice. Cancer Res 65:7007–7012.PubMedCrossRefGoogle Scholar
  29. Mellman, I. and Steinman, R. M. 2001. Dendritic cells: specialized and regulated antigen processing machines. Cell 106:255–258.PubMedCrossRefGoogle Scholar
  30. Munz, C., Steinman, R. M. and Fujii, S. 2005. Dendritic cell maturation by innate lymphocytes: coordinated stimulation of innate and adaptive immunity. J Exp Med 202:203–207.PubMedCrossRefGoogle Scholar
  31. Naik, S. H., Metcalf, D., van Nieuwenhuijze, A., Wicks, I., Wu, L., O'Keeffe, M. and Shortman, K. 2006. Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes. Nat Immunol 7:663–671.PubMedCrossRefGoogle Scholar
  32. Noonan, D. M., De Lerma Barbaro, A., Vannini, N., Mortara, L. and Albini, A. 2008. Inflammation, inflammatory cells and angiogenesis: decisions and indecisions. Cancer Metastasis Rev 27:31–40.PubMedCrossRefGoogle Scholar
  33. Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G. M., Apetoh, L., Perfettini, J. L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., Metivier, D., Larochette, N., van Endert, P., Ciccosanti, F., Piacentini, M., Zitvogel, L. and Kroemer, G. 2007. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med 13:54–61.PubMedCrossRefGoogle Scholar
  34. Palucka, A. K., Ueno, H., Fay, J. W. and Banchereau, J. 2007. Taming cancer by inducing immunity via dendritic cells. mmunol Rev 220:129–150.CrossRefGoogle Scholar
  35. Sapoznikov, A., Pewzner-Jung, Y., Kalchenko, V., Krauthgamer, R., Shachar, I. and Jung, S. 2008. Perivascular clusters of dendritic cells provide critical survival signals to B cells in bone marrow niches. Nat Immunol 9:388–395.PubMedCrossRefGoogle Scholar
  36. Shortman, K. and Naik, S. H. 2007. Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol 7:19–30.PubMedCrossRefGoogle Scholar
  37. Shurin, G. V., Shurin, M. R., Bykovskaia, S., Shogan, J., Lotze, M. T. and Barksdale, E. M., Jr. 2001. Neuroblastoma-derived gangliosides inhibit dendritic cell generation and function. Cancer Res 61:363–369.PubMedGoogle Scholar
  38. Shurin, M. R., Shurin, G. V., Lokshin, A., Yurkovetsky, Z. R., Gutkin, D. W., Chatta, G., Zhong, H., Han, B. and Ferris, R. L. 2006. Intratumoral cytokines/chemokines/growth factors and tumor infiltrating dendritic cells: friends or enemies? Cancer Metastasis Rev 25:333–356.PubMedCrossRefGoogle Scholar
  39. Soares, H., Waechter, H., Glaichenhaus, N., Mougneau, E., Yagita, H., Mizenina, O., Dudziak, D., Nussenzweig, M. C. and Steinman, R. M. 2007. A subset of dendritic cells induces CD4+ T cells to produce IFN-gamma by an IL-12-independent but CD70-dependent mechanism in vivo. J Exp Med 204:1095–1106.PubMedCrossRefGoogle Scholar
  40. Soiffer, R., Lynch, T., Mihm, M., Jung, K., Rhuda, C., Schmollinger, J. C., Hodi, F. S., Liebster, L., Lam, P., Mentzer, S., Singer, S., Tanabe, K. K., Cosimi, A. B., Duda, R., Sober, A., Bhan, A., Daley, J., Neuberg, D., Parry, G., Rokovich, J., Richards, L., Drayer, J., Berns, A., Clift, S., Cohen, L. K., Mulligan, R. C. and Dranoff, G. 1998. Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma. Proc Natl Acad Sci USA 95:13141–13146.PubMedCrossRefGoogle Scholar
  41. Spisek, R., Charalambous, A., Mazumder, A., Vesole, D. H., Jagannath, S. and Dhodapkar, M. V. 2007. Bortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implications. Blood 109:4839–4845.PubMedCrossRefGoogle Scholar
  42. Steinman, R. M., Adams, J. C. and Cohn, Z. A. 1975. Identification of a novel cell type in peripheral lymphoid organs of mice. IV. Identification and distribution in mouse spleen. J Exp Med 141:804–820.PubMedGoogle Scholar
  43. Steinman, R. M. and Banchereau, J. 2007. Taking dendritic cells into medicine. Nature 449:419–426.PubMedCrossRefGoogle Scholar
  44. Steinman, R. M. and Dhodapkar, M. 2001. Active immunization against cancer with dendritic cells: the near future. Int J Cancer 94:459–473.PubMedCrossRefGoogle Scholar
  45. Talmadge, J. E., Donkor, M. and Scholar, E. 2007. Inflammatory cell infiltration of tumors: Jekyll or Hyde. Cancer Metastasis Rev 26:373–400.PubMedCrossRefGoogle Scholar
  46. Ueno, H., Klechevsky, E., Morita, R., Aspord, C., Cao, T., Matsui, T., Di Pucchio, T., Connolly, J., Fay, J. W., Pascual, V., Palucka, A. K. and Banchereau, J. 2007. Dendritic cell subsets in health and disease. Immunol Rev 219:118–142.PubMedCrossRefGoogle Scholar
  47. Yoneyama, H., Matsuno, K., Toda, E., Nishiwaki, T., Matsuo, N., Nakano, A., Narumi, S., Lu, B., Gerard, C., Ishikawa, S. and Matsushima, K. 2005. Plasmacytoid DCs help lymph node DCs to induce anti-HSV CTLs. J Exp Med 202:425–435.PubMedCrossRefGoogle Scholar
  48. Ziegler-Heitbrock, L. 2007. The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J Leukoc Biol 81:584–592.PubMedCrossRefGoogle Scholar
  49. Zou, W. 2005. Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer 5:263–274.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  1. 1.Section of HematologyYale UniversityNew HavenUSA

Personalised recommendations